TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 20:00
TG Therapeutics Shareholders Equity (Quarterly) : 604.08M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 604.08M |
| March 31, 2026 | 583.13M |
| December 31, 2025 | 648.02M |
| September 30, 2025 | 607.22M |
| June 30, 2025 | 276.43M |
| March 31, 2025 | 237.29M |
| December 31, 2024 | 222.36M |
| September 30, 2024 | 192.16M |
| June 30, 2024 | 177.57M |
| March 31, 2024 | 160.11M |
| December 31, 2023 | 160.50M |
| September 30, 2023 | 164.77M |
| June 30, 2023 | 40.45M |
| March 31, 2023 | 27.43M |
| December 31, 2022 | 58.59M |
| September 30, 2022 | 100.48M |
| June 30, 2022 | 129.04M |
| March 31, 2022 | 170.39M |
| December 31, 2021 | 237.15M |
| September 30, 2021 | 311.52M |
| June 30, 2021 | 383.13M |
| March 31, 2021 | 445.28M |
| December 31, 2020 | 519.35M |
| September 30, 2020 | 170.66M |
| June 30, 2020 | 194.23M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.353M |
| December 31, 2019 | 38.62M |
| September 30, 2019 | -25.79M |
| June 30, 2019 | 13.20M |
| March 31, 2019 | 19.25M |
| December 31, 2018 | 24.04M |
| September 30, 2018 | 71.74M |
| June 30, 2018 | 101.38M |
| March 31, 2018 | 85.23M |
| December 31, 2017 | 66.99M |
| September 30, 2017 | 79.55M |
| June 30, 2017 | 77.98M |
| March 31, 2017 | 101.04M |
| December 31, 2016 | 35.87M |
| September 30, 2016 | 56.75M |
| June 30, 2016 | 78.70M |
| March 31, 2016 | 89.45M |
| December 31, 2015 | 101.57M |
| September 30, 2015 | 116.31M |
| June 30, 2015 | 112.95M |
| March 31, 2015 | 106.23M |
| December 31, 2014 | 80.10M |
| September 30, 2014 | 67.08M |
| June 30, 2014 | 52.10M |
| March 31, 2014 | 54.43M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.359B |
| MAIA Biotechnology, Inc. | 20.68M |
| Vericel Corp. | 370.04M |
| Incyte Corp. | 6.344B |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.640B |
| Total Liabilities (Quarterly) | 1.036B |
| Debt to Equity Ratio | 1.249 |
| Current Ratio | 4.267 |
| Net Debt Paydown Yield | -1.19% |